Cara Therapeutics Inc.

Cara Therapeutics Inc. (NASDAQ:CARA)
CARA
69C

Cara Therapeutics, Inc. (NASDAQ:CARA) is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors.

https://www.caratherapeutics.com/
USA

Ratings

There are no reviews yet.

Post your review

Directions to listing

Send Message to listing owner

Cara Therapeutics Inc.